Wenn Sie das Fenster schließen, wird Ihre Konfiguration nicht gespeichert, es sei denn, Sie haben Ihren Artikel in die Bestellung aufgenommen oder zu Ihren Favoriten hinzugefügt.
Klicken Sie auf OK, um das MILLIPLEX® MAP-Tool zu schließen oder auf Abbrechen, um zu Ihrer Auswahl zurückzukehren.
Wählen Sie konfigurierbare Panels & Premixed-Kits - ODER - Kits für die zelluläre Signaltransduktion & MAPmates™
Konfigurieren Sie Ihre MILLIPLEX® MAP-Kits und lassen sich den Preis anzeigen.
Konfigurierbare Panels & Premixed-Kits
Unser breites Angebot enthält Multiplex-Panels, für die Sie die Analyten auswählen können, die am besten für Ihre Anwendung geeignet sind. Unter einem separaten Register können Sie das Premixed-Cytokin-Format oder ein Singleplex-Kit wählen.
Kits für die zelluläre Signaltransduktion & MAPmates™
Wählen Sie gebrauchsfertige Kits zur Erforschung gesamter Signalwege oder Prozesse. Oder konfigurieren Sie Ihre eigenen Kits mit Singleplex MAPmates™.
Die folgenden MAPmates™ sollten nicht zusammen analysiert werden: -MAPmates™, die einen unterschiedlichen Assaypuffer erfordern. -Phosphospezifische und MAPmate™ Gesamtkombinationen wie Gesamt-GSK3β und Gesamt-GSK3β (Ser 9). -PanTyr und locusspezifische MAPmates™, z.B. Phospho-EGF-Rezeptor und Phospho-STAT1 (Tyr701). -Mehr als 1 Phospho-MAPmate™ für ein einziges Target (Akt, STAT3). -GAPDH und β-Tubulin können nicht mit Kits oder MAPmates™, die panTyr enthalten, analysiert werden.
.
Bestellnummer
Bestellinformationen
St./Pkg.
Liste
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Wählen Sie bitte Spezies, Panelart, Kit oder Probenart
Um Ihr MILLIPLEX® MAP-Kit zu konfigurieren, wählen Sie zunächst eine Spezies, eine Panelart und/oder ein Kit.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Spezies
Panelart
Gewähltes Kit
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
96-Well Plate
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
Weitere Reagenzien hinzufügen (MAPmates erfordern die Verwendung eines Puffer- und Detektionskits)
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Platzsparende Option Kunden, die mehrere Kits kaufen, können ihre Multiplex-Assaykomponenten in Kunststoffbeuteln anstelle von Packungen erhalten, um eine kompaktere Lagerung zu ermöglichen.
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Das Produkt wurde in Ihre Bestellung aufgenommen
Sie können nun ein weiteres Kit konfigurieren, ein Premixed-Kit wählen, zur Kasse gehen oder das Bestell-Tool schließen.
SCC189
Sigma-AldrichUM-SCC-105 Human Squamous Carcinoma Cell Line
The HPV18-positive SCC-105 squamous cell carcinoma cell line was derived from the laryngeal tumor of a 51yo never-smoker male and is a suitable in vitro model of H&N carcinoma studies.
More>>The HPV18-positive SCC-105 squamous cell carcinoma cell line was derived from the laryngeal tumor of a 51yo never-smoker male and is a suitable in vitro model of H&N carcinoma studies. Less<<
Empfohlene Produkte
Übersicht
Replacement Information
Description
Catalogue Number
SCC189
Description
UM-SCC-105 Human Squamous Carcinoma Cell Line
Overview
Access to UM-SCC-105 Cells is limited solely to those officers, employees and students of PURCHASER’s institution who need access to perform research. PURCHASER may not distribute UM-SCC-105 Cells or derivatives to third parties. PURCHASER shall comply with all applicable laws in its use and handling of the Product and shall keep it under reasonable safe and secure conditions to prevent unauthorized use or access.
THIS PRODUCT IS ONLY AVAILABLE FOR SALE TO ACADEMIC INSTITUTIONS OR NOT-FOR-PROFIT ENTITIES FOR USE UNDER THIS LIMITED USE LABEL LICENSE. FOR INFORMATION ON COMMERCIAL LICENSING OF UM-SCC-105 CELLS, INCLUDING LICENSING TO COMMERCIAL ENTITIES, PLEASE CONTACT: licensing@milliporesigma.com.
Alternate Names
UMSCC-105
Squamous cell carcinoma cell line
Human squamous cell carcinoma cell line
Human SCC cell line
Background Information
HPV-related head and neck cancers are often more responsive with current therapeutic protocols when compared to HPV-negative tumors that are derived from the same anatomical location. This has propagated interest in reducing the intensity levels of treatment. However, even when combining strong therapeutic approaches with chemotherapy, 20-30% of HPV-positive cancers progress and no longer respond to treatment methods. This makes it continually important to understand why certain tumors progress while others appropriately respond to treatment. The UM-SCC-105 cell line is HPV18-positive. This cell line was biopsied from a laryngeal tumor of a 51-year-old never-smoker male individual. It is understood that the cancer progression was driven by E6/E7 viral mechanisms rather than cell cycle mutations typically related to tobacco smoke carcinogenesis, giving this cell line a unique background. Other mechanisms, such as understanding viral integration into the host genome, continue to be an important aspect of understanding HPV-driven cancers. The UM-SCC-105 cell line positively expresses head and neck cancer markers such as ALDH1, CD44, and ABCG2. ALDH1 and CD44 have both been implicated as cancer stem cell (CSC) markers in head and neck cancers. CSCs are often associated with a poor prognosis and are necessary to understanding aggressive tumor behavior that overcomes treatment. ABCG2 is also addressed as a common head and neck squamous cell carcinoma marker. ABCG2 functions as an efflux pump and is associated with anticancer drug resistance.
Source: The UM-SCC-105 cell line is derived from a biopsied laryngeal tumor of a 51-year-old “never smoker” male.
References: 1. Front Oncol. (2021); 11: 606010. 2. Head Neck (2016); 38(Suppl 1): E459-E467. 3. Head Neck (2017); 39(5): 840-852. 4. Exp Ther Med (2011); 2(6): 1151-1157.
References
Product Information
Components
≥1x106 viable UM-SCC-105 Cells: (Catalog No. SCC189). Store in liquid nitrogen.
The HPV18-positive SCC-105 squamous cell carcinoma cell line was derived from the laryngeal tumor of a 51yo never-smoker male and is a suitable in vitro model of H&N carcinoma studies.
Key Applications
Cell Culture
Application Notes
This product is available for sale to academic institutions or not-for-profit entities for research use. For information on commercial licensing please contact licensing@milliporesigma.com.
Biological Information
Cell Line Type
Cancer Cells
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality Assurance
• Each vial contains ≥ 1X106 viable cells. • UM-SCC-105 cells are verified to be of human origin and negative for mouse, rat, Chinese hamster, Golden Syrian hamster, and non-human primate interspecies contamination, as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services • Cells tested negative for infectious diseases against a Human Essential CLEAR panel by Charles River Animal Diagnostic Services (Cells are HPV18-Positive.) • Cells tested negative for mycoplasma.
Usage Statement
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage Conditions
UM-SCC-105 cells should be stored in liquid nitrogen until use. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.